Candesartan |
Candesartan Products |
| Low hemoglobin predicts poor outcome in diastolic dysfunction; secondary analysis of CHARM program.(News)(Candesartan in Heart Failure Assessment of Reduction ... An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Panel backs candesartan--ACE inhibitor combo.(Cardiovascular Medicine): An article from: Family Practice News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Erythema multiforme associated with candesartan cilexetil.(Case Report): An article from: Southern Medical Journal A. Ahsan Ejaz, John S. Walsh, Andrew Wasiluk Southern Medical Association Southern Medical Association |
Sale Price: $5.95
|
| Panel backs candesartan-ACE inhibitor combo: treating 1,000 patients with candesartan avoided 1,900 days in the hospital for worsening heart failure.(Rx): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Candesartan Tx triples hyperkalemia risk in HF.(Cardiovascular Medicine): An article from: Family Practice News Bruce Jancin Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Candesartan therapy hikes hyperkalemia risk.(Disease/Disorder overview): An article from: Internal Medicine News Bruce Jancin Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| ARB therapy may gain new roles in heart failure care: findings from CHARM program. (angiotensin receptor blocker, Candesartan in Heart Failure: Assessment ... An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| CHARM study backs triple-drug therapy for CHF: undercuts existing guidelines. (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity, ... An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Cardiac drug panel favors candesartan claim of superiority to losartan. (Results of Two, 8-Week Studies).: An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 

